Your session is about to expire
← Back to Search
Behavioural Intervention
Error-enhanced Learning for Stroke Recovery
N/A
Recruiting
Led By James Patton, PhD
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Chronic stroke (8+ months post stroke event) with primary motor cortex involvement
Hemiparesis
Must not have
Severe current medical problems
Bilateral paresis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial uses a robotic arm and virtual reality to help stroke patients practice reaching exercises tailored to their specific mistakes. By understanding and correcting these mistakes, the therapy aims to improve arm movement. Virtual reality (VR) technology is a novel adjunctive therapy that could be applied in neurorehabilitation.
Who is the study for?
This trial is for adults over 18 who have had a stroke at least 8 months ago, affecting the primary motor cortex but still retain some shoulder and elbow movement. It's not suitable for those with severe medical issues, recent Botox in the arm, bilateral paresis, multiple strokes or lesions, severe sensory deficits, high spasticity preventing movement, cognitive impairments that affect task performance or those already in upper extremity rehab.
What is being tested?
The study tests how making mistakes during exercises can help improve arm function after a stroke. Participants will reach for targets using their affected arm while researchers track errors to tailor an exercise program aimed at enhancing recovery based on individual error patterns.
What are the potential side effects?
Since this intervention involves physical exercises tailored to each participant's abilities and error patterns rather than medication or invasive procedures, side effects are minimal but may include muscle soreness or fatigue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had a stroke over 8 months ago affecting my movement control area.
Select...
I have weakness on one side of my body.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have severe health issues right now.
Select...
I have weakness in both sides of my body.
Select...
I have severe difficulty sensing body position and movement.
Select...
I do not have vision problems that stop me from seeing things to my side.
Select...
I have had multiple strokes or have several areas affected by stroke.
Select...
I cannot stay in certain positions for tests.
Select...
I do not have speech, thinking, or mood problems that would affect my participation.
Select...
My severe muscle stiffness hinders my movement.
Select...
I have other neurological conditions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Group 2Experimental Treatment2 Interventions
Group II: Group 1Experimental Treatment2 Interventions
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common stroke treatments, particularly those involving neurorehabilitation like the Customized Reaching Exercise Program (Error-Based Learning), focus on enhancing neuroplasticity through task-specific training and motor learning principles. These methods aim to help the brain form new neural connections, which is essential for recovering motor functions and improving daily activity performance.
By targeting specific movement errors, customized exercises can lead to more effective rehabilitation outcomes, making a significant difference in the recovery process for stroke patients.
Time to reconcile research findings and clinical practice on upper limb neurorehabilitation.Are they really motor learning therapies? A scoping review of evidence-based, task-focused models of upper limb therapy for children with unilateral cerebral palsy.
Time to reconcile research findings and clinical practice on upper limb neurorehabilitation.Are they really motor learning therapies? A scoping review of evidence-based, task-focused models of upper limb therapy for children with unilateral cerebral palsy.
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
208 Previous Clinical Trials
17,905 Total Patients Enrolled
74 Trials studying Stroke
8,747 Patients Enrolled for Stroke
James Patton, PhDPrincipal InvestigatorShirley Ryan AbilityLab
2 Previous Clinical Trials
60 Total Patients Enrolled
2 Trials studying Stroke
60 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe health issues right now.I have weakness in both sides of my body.You have participated in a similar study involving robotics before.I have severe difficulty sensing body position and movement.I do not have vision problems that stop me from seeing things to my side.I have had multiple strokes or have several areas affected by stroke.I cannot stay in certain positions for tests.I have received a Botox injection in my arm within the last 4 months.I had a stroke over 8 months ago affecting my movement control area.I do not have speech, thinking, or mood problems that would affect my participation.I have weakness on one side of my body.I am currently participating in an upper extremity rehabilitation program.I am 18 years old or older.You have trouble feeling things when touched with two points (the distance between the points must be less than 11mm).My severe muscle stiffness hinders my movement.I can move both my shoulders and elbows.I have other neurological conditions.
Research Study Groups:
This trial has the following groups:- Group 1: Group 1
- Group 2: Group 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.